Dr. Larry Gold is the founder, chairman of the board, and CEO of SomaLogic. Prior to SomaLogic, he founded NeXagen, Inc., which later became NeXstar Pharmaceuticals, Inc. In 1999, NeXstar merged with Gilead Sciences, Inc. to form a global organization committed to the discovery, development, and commercialization of novel products that treat infectious diseases. Larry also founded the University of Colorado Gold Lab and is the organizer of the annual Gold Lab Symposium, which brings together experts in the healthcare industry to discuss the impact of innovation on the industry.
Before forming NeXagen, Larry co-founded and served as co-director of research at Synergen, Inc., a pioneering biotechnology company later acquired by Amgen, Inc. Since 1970, Dr. Gold has been a professor at the University of Colorado at Boulder.
Larry has been a member of the American Academy of Arts and Sciences since 1993 and the National Academy of Sciences since 1995.
September 11, 2019
© 2007-2019, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.